Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michele Fox

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPathology, College of Medicine
DivisionPathology Clinical
AddressM1/171 Central Building (old hospital)
4301 W.Markham
Mail Slot # 823
Little Rock AR 72205
Phone501-603-1941
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Rosenbaum E, O'Connell B, Cottler-Fox M. "A successful model for predicting CD34+ cell collection by apheresis". Blood. 2010; 1182a.
    2. Veeraputhiran M, Nakagawa M, Cottler-Fox M. "A comparison of washed and volume-reduced platelets with respect to platelete activation, aggregation and plasma protein removal". Transfusion. 2010; 69A.
    3. Veeraputhiran M, Theus J, Pesek G, Barlogie B, Cottler-Fox M. "Viability of hematopoietic progenitor cells (HPC) and their engraftment after long term cryoperservation: effect of diagnosis and % dimethylsulfoxide (DMSO) concentration". Cryotherapy. 2010; 12(6).
    4. Fox MH. Author Introduction section to Cell Collection for new: AABB Technical Manual in Cell Therapy:Principles, Methods and Regulations . July 2009. p. Author Introduction section to Cell Collection for new. 2009.
    5. Tricot G, Cottler-Fox M, Badel K, Calandra G. Safety and efficacy assessment of perixafor in patients with multiple myeloma proven or predicted to be poor mobilizers including assessment of tumor cell mobilization. Haematologica. 2009.
    6. Shi J, Tricot G, Szmania S, Rosen N, Garg T, Malaviarachchi P, Moreno A, DuPont B, Hsu K, Baxter-Lowe L, Cottler-Fox M, Shaughnessy J, Jr., Barlogie B, Van Rhee F. Transfusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol. 2008; 143(5):641-653.
    7. Tricot G, Cottler-Fox M, Hoering A, Szymonifika J, Van Rhee F, Zangari M, Barlogie B. Mobilization of perifpheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy. Haematologica. 2008; 93(11):1739-1742.
    8. Fox MH, Montgomery M, Theus J. The Clinical Practice of Stem Cell Progenitor/Stem Cell Transplantation. Marrow and Blood Hematopoietic Progenitor/Stem Cell Collection and Processing. 2008.
    9. Shi J, Tricot G, Szmania S, Rosen N, Garg T, Malaviarachchi P, Moreno A, DuPont B, Hsu K, Baxter-Lowe L, Fox MH, Shaughnessy J Jr, Barlogie B, Van Rhee F. Transrusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol. 2008.
    10. Cottler-Fox M, Montgomery M, Theus J. In the Clinical practice of Stem Cell Transplantation. Marrow and Blood Hematopoietic Progenitor/Stem Cell Collection and Processing. 2008.
    11. Montgomery M, Cottler-Fox M. Mobilization and collection of autologous hematopoietic progenitor/stem cells. Clin Adv Hematol Oncol. 2007; 5(2):127 - 136.
    12. Pineda-Roman M, Anaissie E, Zangari M, Bolecack V, Fox MH, Van Rhee F, Tricot G, Hollmig K, Siegel D, Mohiuddin A, Alsayed Y, Gurley J, Jenkins B, Crowley J, Jagannath S, Desikan R, Mehta J, Singhal S, Vesole D, Barlogie B. High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in more than 3000 patients. J Clin Oncol. 2007; Submitted.
    13. Zhan F, Hanamura I, Burington B, Stewart P, Huang Y, Tain E, Colla S, Kordsmeier B, Sawyer J, Hollmig K, Pineda-Roman M, Van Rhee F, Anaissie E, Walker R, Fox MH, Zangari M, Tricot G, Crowley J, Barlogie B, Shaughnessy J. Molecular determinants of high-risk multiple myeloma reflect a central role of genomic abnormalities of chromosome 1. Nature Medicine. 2007; Submitted.
    14. Pineda-Roman M, Fox MH, Hollmig K, Anaissie E, Van Rhee F, Tricot G, Zangari M, Mohuiddin A, Barlogie B. Retrospective analysis of fractioned high-dose melphalan and bortezomib-thalidomide-dexamethasone with autotransplant support for advanced and refractory multiple myeloma. 2006; 3102a.
    15. Gojo I, Meisenberg B, Guo C, Fassas A, Murthy A, Fenton R, Takebe N, Heyman M, Philips GL, Cottler-Fox M, Sarkodee-Adoo C, Ruehle K, French T, Tan M, Tricot G, Rapoport AP. Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma. Bone Marrow Transplant. 2006; 37(1):65 - 72.
    16. Fox CH, Fox MH. Hygiene measures in pandemic flu. Microbe. 2006; 1(4):159.
    17. Anaissie E, Diaz J, Grazziutti M, Miceli M, Fox MH, Barlogie B. Predicting risk of infection and graft vs host disease and response to immunosuppression in allogeneic hematopoietic stem cell transplant patients using the Cyclex/ImmuKnow assay: a pilot study. 2006; 5325a.
    18. Pesek G, Tyler L, Theus J, Nakagawa M, Pellowski D, Fox MH. Extracorporeal photopheresis (ECP), a promising treatment for nephrogenic fibrosing dermopathy (NFD). 2006; 13 (abstract 30).
    19. Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, Van Rhee F, Fassas A, Zangari M, Hollmig K, Pineda-Roman M, Lee C, Talamo G, Thertulien R, Kiwan E, Krishna S, Fox MH, Crowley J. Multiple myeloma survival is not prolonged by the addition of thalidomide to tandem autotransplants. NEJM. 2006; 354(10):1021-1030.
    20. Hsu K, Tricot G, Haessler J, Pinto-Agnello C, Van Rhee F, Fox MH, Dupont B. Lack of predictive value of KIR-HLA genotypes for autologous transplant outcome for multiple myeloma. 2006; 3078a.
    21. Theus J, Van Rhee F, Harville T, Fox MH. Combined plasmapheresis (TPE) and immunosuppressive agents to control high panel reactive antibodies (PRA) in allogeneic blood and marrow transplantation (BMT). 2006; 33 (abstract 80).
    22. Tyler L, Fox MH. Hematopoietic progenitor/stem cell mobilization after prior autologous blood and marrow transplant in myeloma. 2006; 11 (abstract 24).
    23. Cottler-Fox M, Lapidot T. Mobilizing the older patient with myeloma. Blood Rev. 2006 Jan; 20(1):43-50. PMID: 16125290.
      View in: PubMed
    24. Gojo I, Guo C, Sarkodee-Adoo C, Meisenberg B, Fassas A, Rapoport AP, Cottler-Fox M, Heyman M, Takebe N, Tricot G. High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity. Bone Marrow Transplant. 2004; 34(1):69 - 76.
    25. Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport AP, Cottler-Fox M, Tricot G, Ruehle K, Meisenberg B. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion. 2003; 43(1):78 - 84.
    26. Cottler-Fox MH, Lapidot T, Petit I, Kollet O, DiPersio JF, Link D, Devine S. Stem cell mobilization. Hematology Am Soc Hematol Educ Program. 2003; 419 - 437.
    27. Rapoport AP, Meisenberg B, Sarkodee-Adoo C, Fassas A, Frankel SR, Mookerjee B, Takebe N, Fenton R, Heyman M, Badros A, Kennedy A, Jacobs M, Hudes R, Ruehle K, Smith R, Kight L, Chambers S, MacFadden M, Cottler-Fox M, Chen T, Phillips G, Tricot G. Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy. Bone Marrow Transplant. 2002; 29(4):303 - 312.
    28. Fassas AB, Rapoport AP, Bolanos-Meade J, Shanholtz C, Cottler-Fox M, Tricot G. Tamoxifen-based treatment induces clinically meaningful responses in multiple myeloma patients with relapsing disease after autotransplantation. Leuk Lymphoma. 2001; 42(6):1323 - 1328.
    29. Fassas A, Gojo I, Rapoport A, Cottler-Fox M, Meisenberg B, Papadimitriou JC, Tricot G. Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy. Bone Marrow Transplant. 2001; 28(4):399 - 403.
    30. Fassas AB, Buddharaju LN, Rapoport A, Cottler-Fox M, Drachenberg C, Meisenberg B, Tricot G. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation. Leuk Lymphoma. 2001; 42(4):801 - 804.
    31. Hoover SB, Fox CH, Bahre J, Cottler-Fox M, Sung C. Measurement of in situ hybridization. Curr Protoc Mol Biol. 2001; Chapter 14:Unit - .
    32. Yurovsky VV, Cottler-Fox MH, Atamas SP, Shanholtz CB, Britt EJ, Sensenbrenner LL, White B. Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation. Am J Hematol. 2001; 66(1):1 - 11.
    33. Fassas AB, Bolanos-Meade J, Buddharaju LN, Rapoport A, Cottler-Fox M, Chen T, Lovchik JC, Cross A, Tricot G. Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma. Br J Haematol. 2001; 112(1):237 - 241.
    34. Fassas AB, Rapoport AP, Cottler-Fox M, Chen T, Tricot G. Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation. Br J Haematol. 2000; 111(2):662 - 667.
    35. Fox CH, Cottler-Fox M. HIV eradication: thinking the unthinkable. J Hum Virol. 1999; 2(6):321 - 324.
    36. Berlyn KA, Ponniah S, Stass SA, Malone JG, Hamlin-Green G, Lim JK, Cottler-Fox M, Tricot G, Alexander RB, Mann DL, Malone RW. Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy. J Biotechnol. 1999; 73(2-3):155 - 179.
    37. Barrett AJ, Mavroudis D, Tisdale J, Molldrem J, Clave E, Dunbar C, Cottler-Fox M, Phang S, Carter C, Okunnieff P, Young NS, Read EJ. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplant. 1998; 21(6):543 - 551.
    38. Egorin MJ, Rosen DM, Sridhara R, Sensenbrenner L, Cottler-Fox M. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplants. J Clin Oncol. 1998; 16(2):610 - 615.
    39. Liu JM, Young NS, Walsh CE, Cottler-Fox M, Carter C, Dunbar C, Barrett AJ, Emmons R. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients. Hum Gene Ther. 1997; 8(14):1715 - 1730.
    40. Emmons RV, Doren S, Zujewski J, Cottler-Fox M, Carter CS, Hines K, O'Shaughnessy JA, Leitman SF, Greenblatt JJ, Cowan K, Dunbar CE. Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood. 1997; 89(11):4040 - 4046.
    41. Bowman CA, Yu M, Cottler-Fox M. Evaluation of methods for preparing and thawing cryopreserved CD34+ and. Transfusion. 1996; 36(11-12):985 - 988.
    42. Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood. 1996; 88(8):3223 - 3229.
    43. Nash MA, Platsoucas CD, Wong BY, Wong PM, Cottler-Fox M, Otto E, Freedman RS. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector. Hum Gene Ther. 1995; 6(11):1379 - 1389.
    44. Schiffmann R, Medin JA, Ward JM, Stahl S, Cottler-Fox M, Karlsson S. Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene. Blood. 1995; 86(3):1218 - 1227.
    45. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, . Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995; 85(11):3048 - 3057.
    46. Cottler-Fox M, Cipolone K, Yu M, Berenson R, O'Shaughnessy J, Dunbar C. Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Exp Hematol. 1995; 23(4):320 - 322.
    47. Fox CH, Hoover S, Currall VR, Bahre HJ, Cottler-Fox M. HIV in infected lymph nodes. Nature. 1994; 370(6487):256 - .
    48. Dunbar CE, Bodine DM, Sorrentino B, Donahue R, McDonagh K, Cottler-Fox M, O'Shaughnessy J, Cowan K, Carter C, Doren S, . Gene transfer into hematopoietic cells. Implications for cancer therapy. Ann N Y Acad Sci. 1994; 716:216 - 224.
    49. Cottler-Fox M, Klein HG. Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors. Arch Pathol Lab Med. 1994; 118(4):417 - 420.
    50. Purucker ME, Cottler-Fox M. Good response to high-dose intravenous immunoglobulin in patients with alveolar hemorrhage refractory to platelet transfusion. Am J Hematol. 1994; 45(3):269 - 270.
    51. Yu M, Cottler-Fox M. Quality assurance in flow cytometry: comparison of three analytical methods for quantifying CD34+ cells in marrow. Prog Clin Biol Res. 1994; 389:729 - 736.
    52. Cipolone KM, Carter CS, Yu M, Cottler-Fox M. A semi-automated process for antibody sensitization and washing of mononuclear cells prior to CD34+ cell selection. Prog Clin Biol Res. 1994; 389:667 - 673.
    53. Spitzer TR, Areman EM, Cirenza E, Yu M, Dickerson S, Kotula PL, Sacher RA, Cottler-Fox M. The impact of harvest center on quality of marrows collected from unrelated donors. J Hematother. 1994; 3(1):65 - 70.
    54. Cottler-Fox M, Spitzer TR. Immunoglobulin preparations, acute graft-versus-host disease, and infection after marrow transplant. Lancet. 1993; 341(8860):1592 - .
    55. Fox CH, Cottler-Fox M. In situ hybridization in HIV research. Microsc Res Tech. 1993; 25(1):78 - 84.
    56. Cassel A, Cottler-Fox M, Doren S, Dunbar CE. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol. 1993; 21(4):585 - 591.
    57. Dunbar CE, Nienhuis AW, Stewart FM, Quesenberry P, O'Shaughnessy J, Cowan K, Cottler-Fox M, Leitman S, Goodman S, Sorrentino BP, . Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer. Hum Gene Ther. 1993; 4(2):205 - 222.
    58. Karhumaki E, Viljanen ME, Cottler-Fox M, Ranki A, Fox CH, Krohn KJ. An improved enrichment method for functionally competent, highly purified peripheral blood dendritic cells and its application to HIV-infected blood samples. Clin Exp Immunol. 1993; 91(3):482 - 488.
    59. Wilson WH, Jain V, Bryant G, Cowan KH, Carter C, Cottler-Fox M, Goldspiel B, Steinberg SM, Longo DL, Wittes RE. Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors. J Clin Oncol. 1992; 10(11):1712 - 1722.
    60. Fox CH, Cottler-Fox M. The pathobiology of HIV infection. Immunol Today. 1992; 13(9):353 - 356.
    61. Pickle LW, Cottler-Fox M. Statistical methods for the analysis of repeated measurements of serum immunoglobulin levels. Semin Hematol. 1992; 29(3 Suppl 2):116 - 122.
    62. Spitzer TR, Cottler-Fox M, Sullivan P, Lynch M, Tefft MC, Pickle LW, Cirenza E, Cahill R, Deeg HJ, Sacher R. Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation. Semin Hematol. 1992; 29(3 Suppl 2):123 - 126.
    63. Areman EM, Cottler-Fox M. Processing and storage of human bone marrow: do we know enough to set guidelines, standards, and regulations?. J Hematother. 1992; 1(2):103 - 114.
    64. Cottler-Fox M, Read EJ, Yu M, Carter C, Klein HG. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation. Prog Clin Biol Res. 1992; 377:569 - 573.
    65. Read EJ, O'Shaughnessy JA, Yu MY, Cottler-Fox M, Denicoff AM, Cowan KH, Gress RE. Flow cytometric quantitation of circulating hematopoietic progenitor cells in breast cancer patients on chemotherapy. Prog Clin Biol Res. 1992; 377:523 - 530.
    66. Cottler-Fox M, Fox CH. Examining cells for infectious agents: a novel approach. J Infect Dis. 1991; 164(6):1239 - 1240.
    67. Cottler-Fox M, Himoe E, Blancato JK, Deeg HJ. Documentation of allogeneic marrow engraftment by DNA analysis of urinary leucocytes. Br J Haematol. 1991; 79(1):122 - 123.
    68. Cottler-Fox M, Lynch M, Pickle LW, Cahill R, Spitzer TR, Deeg HJ. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels. Bone Marrow Transplant. 1991; 8(1):27 - 33.
    69. Deeg HJ, Spitzer TR, Cottler-Fox M, Cahill R, Pickle LW. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant. 1991; 7(3):193 - 198.
    70. Spitzer TR, Cahill R, Cottler-Fox M, Treat J, Sacher R, Deeg HJ. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature. Cancer. 1990; 66(11):2346 - 2349.
    71. Spitzer TR, Himoe E, Cottler-Fox M, Cahill R, Deeg HJ. Long-term stable mixed chimaerism following allogeneic marrow transplantation for severe aplastic anaemia. Br J Haematol. 1990; 76(1):146 - 147.
    72. Greenspan A, Deeg HJ, Cottler-Fox M, Sirdofski M, Spitzer TR, Kattah J. Incapacitating peripheral neuropathy as a manifestation of chronic graft-versus-host disease. Bone Marrow Transplant. 1990; 5(5):349 - 352.
    73. Cottler-Fox M, Torrisi J, Spitzer TR, Deeg HJ. Increased toxicity of total body irradiation in patients receiving interferon for leukaemia. Lancet. 1990; 335(8682):174 - .
    74. Cottler-Fox M, Bazar LS, Deeg HJ. Isolation of hemopoietic precursor cells from human marrow by negative selection using monoclonal antibodies and immunomagnetic beads. Prog Clin Biol Res. 1990; 333:277 - 284.
    75. Areman EM, Cullis H, Sacher RA, Cottler-Fox M, Deeg HJ. Automated isolation of mononuclear cells using the Fenwal CS3000 blood cell separator. Prog Clin Biol Res. 1990; 333:379 - 385.
    76. Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Bone Marrow Transplant. 1989; 4(5):559 - 565.
    77. Cottler-Fox M, Lynch M, Deeg HJ, Koss LG. Human polyomavirus: lack of relationship of viruria to prolonged or severe hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant. 1989; 4(3):279 - 282.
    78. Raschko JW, Cottler-Fox M, Abbondanzo SL, Torrisi JR, Spitzer TR, Deeg HJ. Pulmonary fibrosis after bone marrow transplantation responsive to treatment with prednisone and cyclosporine. Bone Marrow Transplant. 1989; 4(2):201 - 205.
    79. Deeg HJ, Bazar L, Sigaroudinia M, Spielberg H, Cahill RA, Cohn M, Cottler-Fox M. Inactivation of bone marrow T-lymphocytes by ultraviolet light. Transplant Proc. 1989; 21(1 Pt 3):2938 - .
    80. Deeg HJ, Bazar L, Sigaroudinia M, Cottler-Fox M. Ultraviolet B light inactivates bone marrow T lymphocytes but spares hematopoietic precursor cells. Blood. 1989; 73(2):369 - 371.
    81. Memoli D, Spitzer TR, Cottler-Fox M, Cahill R, Benjamin S, Deeg HJ. Acute esophageal stricture after bone marrow transplantation. Bone Marrow Transplant. 1988; 3(5):513 - 516.
    82. Arnold SG, Whitman JE, Fox CH, Cottler-Fox MH. Latex gloves not enough to exclude viruses. Nature. 1988; 335(6185):19 - .
    83. Fox CH, Cottler-Fox M. HIV infection in the laboratory. Science. 1988; 240(4848):11 - .
    84. Cottler-Fox M, Arvidson K, Hammarlund E, Friberg U. Fixation and occurrence of dark and light cells in taste buds of fungiform papillae. Scand J Dent Res. 1987; 95(5):417 - 427.
    85. Arvidson K, Cottler-Fox M, Hammarlund E, Friberg U. Cytotoxic effects of cobalt-chromium alloys on fibroblasts derived from human gingiva. Scand J Dent Res. 1987; 95(4):356 - 363.
    86. Fox CH, Cottler-Fox M. Second sight: the microscope in medicine. Med Herit. 1986; 2(6):453 - 461.
    87. Fox CH, Cottler-Fox M. AIDS in the human brain. Nature. 1986; 319(6048):8 - .
    88. Junker JL, Cottler-Fox M, Wilson MJ, Munoz EF, Heine UI. Transformation-associated increase of adhesion, cellular fibronectin, and stress fiber development in a liver epithelial cell line. J Natl Cancer Inst. 1985; 74(1):173 - 183.
    89. Cottler-Fox M, Ewaldsson CA, Hansen S, Sedig K, Engardt M, Britton S. Hand function and leprosy. Ethiop Med J. 1984; 22(4):161 - 164.
    90. Arvidson K, Cottler-Fox M, Friberg U. Taste buds of the fungiform papillae in Cynomolgus monkey. J Anat. 1981; 133(Pt 2):271 - 280.
    91. Arvidson K, Cottler-Fox M, Friberg U. Fine structure of taste buds in the human fungiform papilla. Scand J Dent Res. 1981; 89(4):297 - 306.
    92. Fox CH, Cottler-Fox MH, Yamada KM. The distribution of fibronectin in attachment sites of chick fibroblasts. Exp Cell Res. 1980; 130(2):477 - 481.
    93. Cottler-Fox M, Ryd W, Hagmar B, Fox CH. Adhesion of metastatic and non-metastatic carcinoma cells to glass surfaces. Int J Cancer. 1980; 26(5):689 - 694.
    94. Arvidson K, Cottler-Fox M, Friberg U. Effects of dental root posts on human gingival fibroblasts in vitro. J Dent Res. 1980; 59(3):651 - 656.
    95. Cottler-Fox M, Sparring KM, Zetterberg A, Fox CH. The process of epithelial cell attachment to glass surfaces studied by reflexion contrast microscopy. Exp Cell Res. 1979; 118(2):414 - 418.
    96. Fox CH, Auer G, Zetterberg A, Cottler-Fox M. A simple and inexpensive culture device for cell growth, quantitative microscopy and autoradiography. J Microsc. 1978; 112(2):239 - 242.
    97. Fox CH, Selkirk JK, Price FM, Croy RG, Sanford KK, Cottler-Fox M. Metabolism of benzo(a)pyrene by human epithelial cells in vitro. Cancer Res. 1975; 35(12):3551 - 3557.
    98. Heine UI, Weber GH, Cottler-Fox M, Layard MW, Stephenson ML, Zamecnik PC. Analysis of oncornavirus RNA subunits by electron microscopy. Proc Natl Acad Sci U S A. 1975; 72(9):3716 - 3720.
    99. Weber GH, Heine U, Cottler-Fox M, Garon CF, Beaudreau GS. Nucleic acids of RNA tumor viruses: identification and ultrastructure. Virology. 1975; 64(1):205 - 216.
    100. Heine U, Cottler-Fox M. Electron microscopic observations on the composition of herpes-type virions. IARC Sci Publ. 1975; (11 Pt 1):103 - 110.
    101. Weber GH, Dahlberg JE, Cottler-Fox M, Heine U. Electron microscopy of single-stranded RNA from vesicular stomatitis virus. Virology. 1974; 62(1):284 - 287.
    102. Dunkel VC, Bast RC, Gerwin BI, Heine U, Cottler-Fox M, Borsos T. Presence of A-type and absence of C-type virus particles in a chemically induced guinea pig hepatoma. J Natl Cancer Inst. 1974; 53(2):591 - 593.
    103. Weber GH, Heine U, Cottler-Fox M, Beaudreau GS. Visualization of single-stranded nucleic acid of RNA tumor virus with the electron microscope. Proc Natl Acad Sci U S A. 1974; 71(5):1887 - 1890.
    104. Weber GH, Heine U, Cottler-Fox M, Beaudreau G. Direct visualization of labeled nucleotides in DNA using electron microscopy and autoradiography. J Cell Biol. 1974; 61(1):257 - 261.
    105. Fox CH, Cottler-Fox M, Sanford KK. Rapid staining and preservation of cells grown in plastic tissue culture flasks. Stain Technol. 1974; 49(2):105 - 107.
    106. Pesek G, Van Rhee F, Barlogie B, Cottler-Fox M. "Hematopoietic progenitor cell (HPC) collection upon count recovery following autologous transplant". J Clin Apheresis. 28a.
    Fox's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _